T-Rex 2X Long MSTR Daily Target ETF vs DENTSPLY SIRONA Inc — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $39.87 (market cap $809.00M), while DENTSPLY SIRONA Inc trades at $8.82 (market cap $1.73B). The key difference: DENTSPLY SIRONA Inc is far larger — about 2.1× T-Rex 2X Long MSTR Daily Target ETF's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Long MSTR Daily Target ETF for 18 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| MSTU | XRAY | |
|---|---|---|
Market Cap | $809.00M | $1.73B |
Volume | 4,577,465 | 6,198,582 |
Sector | Leveraged / Inverse | Health |
52-Week High | $451.00 | $14.68 |
52-Week Low | $14.60 | $8.52 |
Typical Hold Time | 18 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $39.70, up 0.63% with bearish technical indicators showing 8 buy vs 13 sell signals. The stock faces resistance at $40-$43 with support at $37-$33. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration for H2-2026. Trading activity remains elevated as investors seek leveraged exposure to the underlying company.
The outlook remains cautious with technical weakness outweighing neutral oscillators. Key risks include the leveraged ETF structure's daily rebalancing effects and dependence on underlying stock volatility. Investment appeal hinges on continued institutional interest in the strategy exposure, though the bearish technical setup suggests near-term pressure.
DENTSPLY SIRONA (XRAY) trades at $8.83, down 3.4% with bearish technical signals. The stock faces fundamental challenges with negative net income margins (-14.99%) and declining revenue trends ($3.68B in 2025). Recent Q2 2026 earnings beat expectations but sales fell 4.1% amid ongoing turnaround efforts. The company maintains strong institutional interest despite hitting 52-week lows in September 2026.
XRAY presents a high-risk opportunity with Wall Street maintaining a cautious stance (37.5% buy rating). The consensus price target of $13.40 offers 52% upside potential, but investors face execution risks in the dental equipment turnaround, margin pressures, and competitive challenges. Near-term catalysts include management's presentation at the Baird Healthcare Conference in September 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →